doi: 10.7759/cureus.92454
Semaglutide is also contraindicated in patients with a personal or family history of MTC or in patients with MEN 2, and in patients with a hypersensitivity reaction to semaglutide
Evidence on GLP-1 receptor-based drugs and ED are scant and have been mostly accrued in animal models and people with diabetes
Supplements may not contain what they advertise, and sometimes can contain unregulated amounts of prescription medications, which can be dangerous
Endocrinology 137:23832388 Rouille Y, Martin S, Steiner DF (1995) Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide
Nausea affects approximately 15-20% of patients, with vomiting (5-9%), diarrhea (8%) and abdominal pain (6-7%) also common